GLASF - Investing In Marijuana Stocks Here Are 3 To Know About
2023-11-29 07:00:27 ET
3 Top Marijuana Stocks For You To Research Before Investing
Investing in marijuana stocks has gained more attention for several reasons. The global trend toward legalization, both for medical and recreational use, is expanding the market significantly. Projections suggest the legal cannabis market could achieve larger amounts of yearly revenue. Medical applications of cannabis, especially in treating conditions like chronic pain and epilepsy, contribute to the industry’s growth. In addition to the recreational side of legal cannabis.
Changing attitudes toward cannabis overall also reflect shifting consumer trends, expanding the potential customer base. For investors seeking diversification, finding marijuana stocks to buy offers an alternative sector to invest in with unique dynamics. Additionally, ongoing innovation and research in the field contribute to product differentiation and market competitiveness. Beyond financial considerations, the cannabis industry’s growth has broader economic implications. It can generate employment opportunities and stimulate economic development, particularly in regions where legalization occurs.
However, potential risks versus rewards must be acknowledged. Regulatory challenges are paramount, with varying legal statuses across the USA. Changes in regulations can significantly impact the industry, leading to uncertainties for investors. Operational challenges, such as scaling up production while maintaining quality, and the industry’s inherent volatility are additional factors to consider. The competitive landscape is intensifying, favoring companies with strong brands, distribution networks, and product quality. Which also leads to more people becoming interested in investing in top marijuana stocks. Before investing, thorough research is essential, and having a trading strategy. The companies below are several cannabis stocks to watch heading into 2024.
Marijuana Stocks To Watch Right Now
- Cansortium Inc. ( OTC:CNTMF )
- StateHouse Holdings Inc. ( OTC:STHZF )
- Glass House Brands Inc. ( OTC:GLASF )
Cansortium Inc.
Cansortium Inc. through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company’s medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, and edibles under the Fluent brand name.
In the more recent company news Cansortium Inc. will reschedule its Q3 2023 conference call. The new date for the call is Wednesday, November 29th at 4:30 P.M. The Company will issue a press release with its results prior to the call. Cansortium management will host the conference call, followed by a question-and-answer period.
StateHouse Holdings Inc.
StateHouse Holdings Inc. an integrated omni-channel cannabis company, engages in the cultivation, processing, manufacture, distribution, and retailing of cannabis products for the adult-use and medical markets in the United States.
In recent news, the company has issued consideration for increased interest in Haight Ashbury dispensary. So SateHouse has completed the issuance of shares related to its acquisition of a further 29.9% interest in FGW Haight, Inc. The FGW Acquisition has increased the Company’s interest in Harborside San Francisco to 80%.
[Read More] 3 Top Marijuana Stocks For Cannabis Investors Today
Glass House Brands Inc.
Glass House Brands Inc. through its subsidiaries, cultivates, manufactures, and distributes cannabis bulk flowers and trims to wholesalers in California.
In recent news, the company reported record-breaking third-quarter 2023 financial results.
[Read More] Top Marijuana Stocks For The 2024 Green Rush
Q3 2023 Highlights And Key Mentions
- Cash increased to $37.9 million from $22.7 million in Q2 2023, including about $5 million in capex spend and a $12.8 million inflow from Series D Preferred Equity Fund Raise
- Operating cash flow reached a record $9.1 million versus $8.3 million in Q2 2023
- Adjusted EBITDA1 was $10.7 million versus $9.5 million in Q2 2023
- Revenue was a record $48.2 million, up 8% sequentially and 71% year-over-year
- Gross margin was 54% versus 55% in Q2 2023 versus 31% in the prior year period
- Q3 Biomass revenue increased 142% year-on-year and production was up 36% year-over-year
- Cost per Equivalent Dry Pound of Production2,3 dropped to a record low $118 per pound, down 12% versus Q3 2022
- Average selling price was $336 per pound, up 65% versus last year